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Abstract
Introduction: Communication campaigns are incorporating tobacco constituent messaging to 
reach smokers, yet there is a dearth of research on how such messages should be constructed or 
will be received by smokers.
Methods: In a 2 × 2 × 2 experiment, we manipulated three cigarette constituent message compo-
nents: (1) the toxic constituent of tobacco (arsenic vs. lead) with a corresponding health effect, (2) the 
presence or absence of an evocative image, and (3) the source of the message (FDA vs. no source). 
We recruited smokers (N = 1669, 55.4% women) via an online platform and randomized them to one 
of the eight message conditions. Participants viewed the message and rated its believability and per-
ceived effectiveness, the credibility of the message source, and action expectancies (ie, likelihood of 
seeking additional information and help with quitting as a result of seeing the message).
Results: We found significant main effects of image, constituent, and source on outcomes. The use of 
arsenic as the constituent, the presence of an evocative image, and the FDA as the source increased the 
believability, source credibility, and perceived effectiveness of the tobacco constituent health message. 
Conclusions: Multiple elements of a constituent message, including type of constituent, imagery, 
and message source, impact their reception among smokers. Specifically, communication cam-
paigns targeting smokers that utilize arsenic as the tobacco constituent, visual imagery, and the 
FDA logo may be particularly effective in changing key outcomes that are associated with subse-
quent attitude and behavioral changes.
Implications: This article describes how components of communication campaigns about ciga-
rette constituents are perceived. Multiple elements of a tobacco constituent message, including 
type of constituent, image, and message source may influence the reception of messages among 
current smokers. Communication campaigns targeting smokers that utilize arsenic as the tobacco 
constituent, visual imagery, and the FDA logo may be particularly effective in changing key out-
comes among smokers. The effects of such campaigns should be examined, as well as the mecha-
nisms through which such campaigns affect change.
Introduction
Tobacco use is the leading cause of preventable death in the United 
States.1 Much of the harm from smoking comes from chemicals (ie, 
constituents) present in cigarettes and cigarette smoke. Of the 5000 
constituents in a single cigarette, at least 70 are recognized carcin-
ogens.2 The US Food and Drug Administration (FDA) has recently 
required manufacturers to report harmful and potentially harmful 
constituents (HPHCs) in tobacco products.3 Upon receiving reports 
from tobacco manufacturers, the FDA is required to communicate 
this information to the public in a “format that is understandable and 
not misleading to lay persons.”3 Within the context of the The Real 
Cost campaign (a media campaign that seeks to educate at-risk teens 
about the harmful effects of tobacco use), the FDA has begun commu-
nicating information about tobacco constituents. For instance, in one 
advertisement (“Science Class”), the harmful effects of cigarette con-
stituents (specifically, formaldehyde, acrolein, and nitrobenzene) are 
represented as a dangerous creature. This type of messaging, where 
descriptive statements about chemical constituents in cigarettes and 
their health effects are used, represents a shift from previous quantita-
tive disclosures on cigarette packs about constituents and emissions 
(tar, nicotine, and carbon monoxide), which may mislead consumers 
to believe brands with lower yields are less harmful.4,5
Few studies have examined the effectiveness of tobacco commu-
nication campaigns where constituents are part or all of the mes-
saging. Evidence indicates that consumers are often unaware of 
constituents in tobacco products or smoke and their harm6 and that 
some types of constituent messaging can increase consumer’s knowl-
edge of constituents, knowledge about the health risks of smoking, 
and cognitive elaboration.4,5,7 However, more research examin-
ing characteristics of health messages that only focus on cigarette 
constituents may be helpful in understanding effective constituent 
messages. Therefore, our study sought to examine characteristics 
of cigarette constituent messages among smokers by manipulating: 
the nature of the cigarette constituent (arsenic vs. lead), the use of 
visual imagery (image of a skull formed of cigarette smoke vs. no 
image), and the source of the message (FDA vs. no source). We chose 
these three manipulations based on previous research documenting 
the effectiveness of visual imagery in general tobacco communica-
tion campaigns,8 the importance of source credibility on attitudes 
and behavioral intentions,9 and evidence suggesting constituents 
such as lead and arsenic may discourage smokers from wanting to 
smoke cigarettes.6,10 We intended to develop communication mes-
sages that evoked the serious consequences of cigarette smoking and 
hypothesized that messages that included visual imagery and a cred-




We administered the experiment via Amazon Mechanical Turk 
(MTurk), a web-based platform that is frequently used for survey 
and behavioral research.11 For our study, we limited inclusion to 
adults (18+) in the United States who reported smoking cigarettes in 
the past 30 days, and paid $3.50 for participation. The University of 
North Carolina at Chapel Hill IRB approved this study (#15–1952); 
all participants completed informed consent. To ensure high-quality 
data, we excluded participants who failed any of the three atten-




For this experiment, we manipulated three components of a health 
message on cigarette constituents in a 2 × 2 × 2 design: the message 
about a toxic constituent found in cigarettes (arsenic vs. lead) with 
a corresponding health effect, the image (the presence vs. absence of 
a smoky skull), and the source of the message (FDA vs. no source). 
The arsenic message read as: “Cigarette smoke contains arsenic. This 
causes lung tumors” and the lead message read as: “Cigarette smoke 
contains lead. This causes brain disorders.” Participants were able to 
view the messages for as long as they wanted. An example message 
can be seen in Figure 1 (Supplementary Appendix A).
Outcomes
We assessed four outcomes: message believability, source credibility, 
perceived message effectiveness, and action expectancies. We meas-
ured believability with two items assessing whether the messages 
were believable and convincing (α = 0.89).12 We measured source 
credibility with three items assessing whether the sponsor of the mes-
sages was credible,13 trustworthy,14 and an expert13 (α = 0.94). We 
measured perceived effectiveness with three items assessing whether 
the messages discouraged participants from smoking, made smoking 
seem unpleasant, and made them concerned about the health effects 
of smoking (α = 0.83) (Baig SA, Gottfredson NC, Noar SM, Boynton 
MH, Ribisl KM, Brewer NT, unpublished data). We measured action 
expectancies with two items that assessed participants’ likelihood of 
seeking information about chemicals in cigarettes and seeking help 
to quit smoking as a result of seeing the message (α = 0.83). We 
assessed all outcomes on a 5-point scale and averaged scores.
Background Variables
All participants provided information on sex, race, ethnicity, educa-
tion, age, smoking status, and FDA’s credibility as a tobacco regulator 
(Supplementary Appendix B). We measured smoking status with the 
item “Do you now smoke cigarettes every day, some days, or not at 
all?” and dichotomized responses as “every day smokers” and “some 
days smokers”. Nonsmokers were screened out of the study. Because 
the FDA is a government agency, we also measured credibility in the 
FDA as a tobacco regulator using a six-item validated scale (α = 0.82).15
Data Analysis
We used SAS version 9.3 for analysis. We entered all variables simul-
taneously in one-way analyses of covariance (ANCOVA) models 
to compare mean differences among the three experimental factors 
for each of our four outcomes. Results from the ANCOVA models 
included F-values, p-values, and effect sizes (semi-partial eta-squared; 
small effect size = 0.01, medium = 0.06, large = 0.14).16 Additionally, 
we conducted analyses that included two-way interactions of each 
of three experimental conditions and smoking status to determine if 
combinations of the health message characteristics affected percep-
tions. For source credibility as the outcome, we also examined interac-
tions between the manipulation of the source and perceived credibility 
in the FDA as a tobacco regulator. We set the alpha level at p < .05.
Results
Descriptive Statistics
Our sample of adult smokers (n = 1669) was mostly white (82.4%), 
non-Latino (88.5%) and on average, 34.2 years old (Supplementary 
Appendix C). Participants reported moderate credibility in the 
FDA as a tobacco regulator (mean, M  =  3.6, standard deviation, 
SD = 0.8). Correlations among the four outcomes were moderate to 
strong (range = .41 to .78).
Main Effects and Interactions for Experimental 
Conditions
We found significant main effects for each of the three experimental 
conditions (Table 1). Participants in the arsenic condition reported 
the messages as more believable (p < .001) and the source as more 
credible (p  <  .001), but perceived the message as less actionable 
(p = .03) than participants in the lead condition. Participants in the 
evocative image condition reported the messages as more believable 
(p < .001), the source as more credible (p = .01), and the message as 
more effective (p <  .001) than participants in the no-image condi-
tion. Participants in the FDA logo condition reported the source as 
more credible (p < .001) than participants in the no source condi-
tion (without the FDA logo). There were no significant interactions 
between the experimental manipulations. Effect sizes for the manip-
ulations were small, ranging from 0.01 to 0.02.
Effects of Background Variables
Perceptions of the messages were influenced by sex, smoking sta-
tus, and perceived credibility of the FDA as a tobacco regulator 
(ANCOVA results). Males reported the messages to be less believ-
able (F = 6.29, p = .01) and effective (F = 7.47, p = .01) than females. 
Daily smokers reported the messages to be less effective (F = 14.4, 
p = .001) and actionable (F = 7.6, p = .01) than some-days smokers. 
Perceived credibility of the FDA was positively associated with mes-
sage believability (F = 208.6, p < .001), source credibility (F = 316.0, 
p < .001), perceived effectiveness (F = 144.8, p < .001), and action 
expectancies (F = 62.9, p < .001). Effect sizes for the effects of back-
ground variables on the four outcomes ranged from 0 to 0.15.
There was a significant interaction between perceived credibility 
of the FDA and the source manipulation (p = .01). Specifically, for 
individuals who perceived the FDA to have high credibility (M + 
Figure 1. Example experimental condition with arsenic as the constituent, and skull image and FDA logo both present. For this experiment, we manipulated the 
constituent of the message (arsenic vs. lead), whether the message has an image (smoky image background vs. not) and the source of the message (FDA vs. 
not). For the constituent, the message could either be related to arsenic (presented in the figure) or lead (with text stated “Cigarette smoke contains lead. This 
causes brain disorders.”). All messages had the “Contains” brand and “Ready to be tobacco free? You can quit. For free help, go to smokefree.gov.”
1 SD), the presence of the FDA logo increased source credibility. 
However, for individuals who perceived the FDA to have low cred-
ibility (M − 1 SD), the FDA logo had no effect on source credibility. 
There were no significant interactions between smoking status and 
the experimental conditions.
Discussion
In this study, we found that messages that specified arsenic as a con-
stituent and used the FDA logo increased message believability and/
or source credibility, and the presence of the visual image increased 
believability, source credibility, and perceived effectiveness. The fact 
that participants rated messages reporting arsenic in tobacco as 
more believable and the source as more credible than lead is con-
sistent with a previous study finding higher consumer awareness of 
arsenic as a constituent in cigarette smoke than lead.10 However, in 
this same study, participants reported both lead and arsenic to be 
equally harmful and discouraging.10 Given these results, it is possible 
that participants in our study were less aware of lead and its health 
effects (“brain disorder”) compared to arsenic (“lung tumors”) and 
thus more likely to want to seek out information about constitu-
ents or quit smoking (ie, heightened action expectancies). This might 
explain why we observed decreased message believability and source 
credibility, but increased action expectancies, when lead was the con-
stituent as opposed to arsenic.
Previous research on tobacco warnings found that messages 
containing visual imagery were more effective and powerful than 
no-imagery messages.8,17,18 For instance, in an experimental study 
examining pictorial warnings or text-only warnings on cigarette 
packs, participants who received the pictorial warnings rated the 
warnings as significantly more salient, credible, and impactful than 
participants who received the text-only warnings, regardless of race, 
education, or income.8 These findings are supported by a relevant 
body of research on health warnings for tobacco products, including 
recent reviews and a meta-analysis, which documented the benefits 
of pictorial warnings over text-only warnings.17,18 Our manipulation 
on the use of visual imagery for tobacco constituents, through the 
presence of a skull formed of cigarette smoke, supports and extends 
this research to messaging about constituents.
Source credibility affects how positively messages are received.9 
For instance, in an experiment manipulating the source of smoking 
cessation advertisements, researchers found that messages sponsored 
by a tobacco company were less credible than ads sponsored by 
public health agencies and that credibility was associated with per-
ceived ad effectiveness for nonsmokers.19 While additional research 
is needed regarding source credibility in tobacco communication 
campaigns, particularly regarding behavioral outcomes, it may be an 
important component of health messages that should be considered 
by researchers and policy makers. Although many individuals are 
unaware of the FDA’s tobacco regulatory authority or may doubt the 
credibility of the FDA,20 we found that the presence of the FDA logo 
enhanced the source credibility of a cigarette constituent message. 
Moreover, we found that these differences were most pronounced 
among individuals who perceived the FDA as a credible tobacco 
regulator. Thus, individual characteristics may interact with message 
characteristics to influence receptivity to tobacco communication 
campaigns.
Lastly, we found that certain subgroups (ie, men, everyday smok-
ers, individuals with lower perceived credibility in FDA) were less 
likely to report the constituent messages as impactful—regardless of 
condition. Further research examining how tobacco communication 
campaigns about constituents are perceived among these popula-
tions is warranted.6
Limitations
The present study had some limitations. First, viewing the messages 
online differs from how participants may view the messages in real 
life and introduces some concerns about ecological validity. Second, 
we manipulated the presence or absence of a source rather than a 
credible source versus a not credible source; relatedly, it is possible 
that participants thought both ads were sponsored by the govern-
ment due to the language “for free help, go to smokefree.gov.” Third, 
effect sizes for the impacts of these manipulations on outcomes were 
small. Finally, there is little research examining whether manipula-
tions of source credibility are associated with changes in smoking 
or other behavioral outcomes. Some research suggests that source 
credibility may be associated with message effectiveness, particularly 
when credible sources versus noncredible sources are compared,19 
but other research suggests that tobacco messages heard over the 
phone without a source may be just as believable as messages with 
a governmental source (ie, Surgeon General, FDA, CDC).21–23 Given 
Table 1. Effects of the Experimental Factors Manipulated
Outcome
Experimental factor Believability Source credibility Perceived effectiveness Action expectancies
Constituent
Arsenic, mean (SD) 3.81 (1.06) 3.74 (1.01) 3.45 (1.12) 2.77 (1.19)
Lead, mean (SD) 3.50 (1.20) 3.49 (1.16) 3.43 (1.17) 2.88 (1.21)
F = 31.78, p < .001, η2 = 0.02 F =  23.05, p < .001, η2 = 0.01 F = .01, p = .92, η2 = 0.00 F = 4.86, p = .03, η2 = 0.003
Image
Present, mean (SD) 3.79 (1.11) 3.70 (1.09) 3.54 (1.11) 2.87 (1.21)
Absent, mean (SD) 3.51 (1.16) 3.53 (1.09) 3.33 (1.18) 2.78 (1.19)
F = 22.55, p < .001, η2 = 0.02 F = 7.27, p = .01, η2 = 0.004 F = 13.45, p < .001 η2 = 0.01 F = 1.94, p = .16, η2 = 0.001
Source
FDA, mean (SD) 3.71 (1.14) 3.79 (1.07) 3.48 (1.13) 2.88 (1.19)
None, mean (SD) 3.60 (1.14) 3.44 (1.09) 3.39 (1.17) 2.77 (1.21)
F = 2.76, p = .10, η2 = 0.001 F = 45.02, p < .001, η2 = 0.02 F = 1.72, p = .23, η2 = 0.001 F = 3.61, p = .11, η2 = 0.002
ANCOVA controlled for age, sex, race/ethnicity, education, credibility of the FDA as a tobacco regulator, and smoking status. For each experimental factor, the 
DFmodel and DFerror were (17, 1651). Bolded mean pairs are those that are statistically significant (p < .05).
the lack of previous research, particularly regarding behavioral 
outcomes, and the limitations of the present study discussed above, 
additional research on source credibility is warranted.
Conclusions
The present study provides some of the first evidence regarding how 
tobacco constituent messages are perceived by current smokers. Our 
findings indicate that cigarette communication campaigns about 
constituents that utilize arsenic as the tobacco constituent, visual 
imagery, and the FDA logo may be particularly effective in changing 
key outcomes among smokers.
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Supplementary data are available at Nicotine and Tobacco Research online.
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